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~hagocytic cells contain a complicated  enzyme system, 
termed  NADPH  oxidase,  that  is  responsible  for  the 
production of toxic oxygen species (1). The enzyme transfers 
electrons from NADPH to 02, forming O2-, which then 
can dismutate into H202.  Subsequently,  other oxygen de- 
rivatives, such as hydroxyl radical and hypochlorous acid, may 
be formed. Collectively, these oxygen products are toxic to 
components in their environment, either phagocytosed  or 
extracellular  microorganisms or surrounding tissue  (1, 2). 
Thus, the NADPH oxidase of phagocytic cells is an impor- 
tant participant in both host defense and inflammatory mech- 
anisms. This is well-illustrated by the genetic disorder, chronic 
granulomatous disease (CGD), in which the NADPH oxi- 
dase enzyme is defective. Patients with CGD suffer from fre- 
quent and severe infections, as well as noninfectious compli- 
cations,  such as lymphadenopathy and hepatomegaly (3). 
Components of  NADPH Oxidase.  The NADPH oxidase 
enzyme consists of at least four polypeptide components (1, 
3, 4). Two of the components, termed gp91-phox and p22- 
phox, form an unusual heterodimeric cytochrome b, cyto- 
chrome bsss. The other two components, termed p47-phox 
and p67-phox, are cytosolic proteins that assemble with cyto- 
chrome bsss during activation  of the enzyme. The nomen- 
clature used designates the size of each protein by SDS-PAGE 
and indicates that each protein is a component of the phago- 
cyte oxidase ("gp" denotes glycoprotein, "p" denotes protein). 
At least one additional protein, the small GTP-binding pro- 
tein Rac (either Racl or Rac2), is needed for NADPH oxi- 
dase activation (5-7). The mechanism by which GTP-bound 
Rac influences the enzyme is unknown, but is under intense 
investigation  (8, 9). A sixth oxidase-related protein, termed 
p40-phox, recently has been identified (10, 11), which has se- 
quence similarity  to p47-phox and p67-phox and appears to 
physically associate with p67-phox. Defects in any of the four 
genes that code for components of the NADPH oxidase en- 
zyme system can cause CGD (3).  In most cases, the gene 
defect results in the absence of the protein product and, thus, 
the absence of NADPH oxidase activity. Both gp91-phox and 
p22-phox are usually absent if either gene is defective, sug- 
gesting each is unstable without the other. A few cases have 
been reported where cytochrome bsss is present,  but non- 
functional,  and these are usually caused by point mutations 
in the gene for either gp91-phox  or p22-phox. These have been 
particularly informative for gaining insights into structure/ 
function relationships,  as discussed below. Additional infor- 
mation on the molecular genetics of CGD can be found in 
recent excellent reviews (3,  12). 
Activation ofNADPH Oxidas~  NADPH oxidase is inac- 
tive until the cell is stimulated  by phagocytosis  or various 
inflammatory mediators (e.g., chemoattractants,  cytokines). 
Binding of an agonist to its cell-surface receptor triggers var- 
ious signal transduction pathways (13). While a number of 
signaling intermediates (e.g., phospholipases, protein kinases) 
have been implicated as regulators of NADPH oxidase acti- 
vation, a complete pathway has not been defined. Complexity 
is increased by the likelihood that multiple pathways are in- 
volved (14, 15). However, it is dear that activation of NADPH 
oxidase culminates in assembly  ofp47-phox and p67-phox with 
cytochrome bsss in the membrane (16-21). With the devel- 
opment of a cell-free system that models the assembly/acti- 
vation process (3, 22-26) and the cloning of the NADPH 
oxidase components, it has been possible to begin addressing 
the structural features of the components involved. 
Structure of  NADPH Oxidase Components.  Cloning of the 
four NADPH oxidase components (27-32) has revealed that 
the predicted sequence of each protein is unique, with only 
limited regions of similarity to other known proteins.  The 
gp91-phox subunit of cytochrome bsss has weak homology 
to NADPH and FAD binding sites found in the ferredoxin 
reductase family of flavoproteins (33-36).  This suggests that 
cytochrome bsss may be a flavocytochrome, capable of car- 
tying out the entire electron transfer from NADPH to O2. 
Recent modds (36, 37) postulate that a conformational change 
in gp91-phox is needed to either enhance NADPH binding 
and/or fadlitate dectron transfer between NADPH and FAD. 
Such a conformational change could be induced by assembly 
of the cytosolic components with the cytochrome.  Experi- 
mental support for cytochrome bsss as a flavocytochrome has 
appeared from several laboratories  (20,  33-35,  38,  39),  al- 
though the modal is not universally accepted (40,  41). 
Several predicted structural features of p47-phox and p67- 
phox also are of interest. The COOH-terminal region ofp47- 
phox contains six to eight clustered putative phosphorylation 
sites. It has been shown that p47-phax  is phosphoryhted during 
stimulation  of intact neutrophils,  yidding up to eight phos- 
phospecies ranging from •pI  6.8 to 10 (42-44).  Phosphory- 
lation of the dustered sites could dramatically alter the con- 
formation of the protein (43). However, direct evidence that 
phosphorylation of p47-phox is required for NADPH oxi- 
dase activation is lacking (45-48).  Both p47-phox and p67- 
phox contain another important structural feature, Src ho- 
mology 3 (SH3) domains. Each protein contains two of these 
regions (Fig. 1). The newly described p40-phox also contains 
one SH3 region (10). SH3 domains were originally described 
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Figure  1.  Schematic  diagram showing  positions of the SH3 domains 
of  the cytosolic  NADPH  ~idase components  p47-phox  and p67-phox  (32). 
Each SH3 region is comprised  of about 60 amino acid residues. 
in the Src family of tyrosine kinases  and are found in a va- 
riety of proteins involved in signal transduction (49).  They 
appear to mediate protein-protein interactions via binding 
to proline-rich sequences in target proteins (50).  Several of 
the oxidase components contain proline-rich sequences that 
could be binding sites for SH3 domains (51-53).  It is likely 
that SH3-mediated protein-protein interactions are involved 
in NADPH oxidase assembly, as discussed more fully below. 
Requirement  for SH3 Domains in NADPH Oxidase Activa- 
tion.  The SH3 regions of both p67-phox and p47-phox are 
necessary for NADPH oxidase activation. A role for the SH3 
domain of p40-phox has not been explored.  Studies by de 
Mendez et al. (54) showed that deletion mutants of p67-phox, 
lacking one or both SH3 regions, were unable to restore the 
ability to activate NADPH oxidase when transfected into p67- 
phox-deficient B cell lines derived from patients with this 
form of CGD. In contrast, p67-phox  mutant proteins lacking 
the SH3 regions were active in a cell-free reconstitution system. 
This suggests that the SH3 domains ofp67-phox are required 
for a signaling function in the intact cell, but this function 
is bypassed or replaced by the activator in the cell-free system. 
The non-SH3 portion of p67-phox is still needed in the cell- 
free system and, thus,  must have an additional function in 
the assembly/activation process.  Evidence is emerging that 
the two SH3 regions ofp47-phox also are critical for assembly 
of an active NADPH  oxidase,  in both transfected cell and 
cell-free systems. Preliminary results from Leto et al. (55) in- 
dicate that truncated forms of p47-phox lacking one or both 
SH3 regions are inactive in the B cell transfection model. 
Also,  Sumimoto et al. (53) demonstrated inhibition of cell- 
free activation of NADPH oxidase by a glutathione-S-trans- 
ferase (GST)-fusion protein containing the two SH3 domains 
of p47-phox (GST-p47-SH3),  presumably acting as a com- 
petitive inhibitor for SH3-dependent interactions mediated 
by the native protein. 
Interaction  of  SH3 Domains  with  Pro-rich  Sequences  in NADPH 
Oxidase Components.  Several groups recently have identified 
interactions between proline-rich sequences in NADPH oxi- 
dase components and SH3  domains of p47-phox and p67- 
phox. Table 1 lists the Pro-rich sequences present in NADPH 
oxidase components, based on consensus sequences identified 
in other proteins (50). At least three possible SH3 region/Pro- 
rich sequence interactions have experimental support, and each 
will be described separately. The first is binding between the 
second SH3 domain of p67-phox and the COOH-terminal 
Pro-rich sequence in p47-phox. Finan et al. (52) showed that 
a GST-fusion protein, containing the second SH3 domain of 
p67-phox, bound to p47-phox. Leto et al. (51), in a complemen- 
Table 1.  Proline-rich  Sequences  in NADPH Oxidase Components 
Component*  Sequencer 
p22-phox 
133-142  __P I EPKPRERP 
149-162  KQPPSNPPPRPPAE 
176-190  AGGPPGGPQVNP I PV 
p4  7-phox 
70-83  R I I PHLPAPKWFDG 
338-351  QARPGPQSPGSPLE 
358-371  RSKPQPAVPPRPSA 
p6  7-phox 
219-235  PLQPQAAEPPPRPKTPE 
* Residue numbers corresponding  to sequences  are provided. 
* Given in single  letter code. Positions  of prolines conserved  in functional 
Pro-rich sequences  of other proteins are underlined (50-52). 
tary series of experiments, came to a similar conclusion. Both 
groups pinpointed the SH3 binding site to a COOH-terminal 
Pro-rich sequence in p47-phax (aa 362-369), using either syn- 
thetic peptide inhibitors or GST-fusion proteins containing 
truncated forms ofp47-phox. Sumimoto et al. (53) also have 
proposed an SH3-dependent interaction between p47-phox 
and p67-phox. A GST-fusion protein containing the SH3 do- 
mains of p47-phox bound p67-phox, only in the presence of 
the cell-free reconstitution system activator arachidonic acid. 
Binding site(s)  in p67-phox  were not identified. Thus,  this 
interaction differs from that described by Finan et al.  (52) 
and Leto et al.  (51), in that the SH3 domains of p47-phox, 
rather than an SH3 region of p67-phox, mediates binding of 
the two proteins.  It remains to be determined whether ei- 
ther or both interactions occur in  the intact cell. 
The second interaction involves binding of the SH3 do- 
mains of p47-phox to a cytoplasmic region of p22-phox con- 
taining three Pro-rich sequences.  Evidence to  support  this 
interaction comes from three different groups. Sumimoto et 
al.  (53)  showed that a GST-fusion protein containing both 
SH3 domains of p47-phox  bound to GST-fusion proteins con- 
taining the two most COOH-terminal, or only the middle, 
Pro-rich sequence of p22-phox. A  natural mutation in the 
middle Pro-rich region in p22-phox  (P156Q) has been reported 
in a patient with CGD (56).  This mutation was introduced 
into GST-fusion proteins and resulted in markedly reduced 
binding of GST-p47-SH3. Leto et al, (51) obtained the same 
results using a similar series of GST-fusion proteins. This group 
also showed that synthetic peptides containing the middle 
Pro-rich  sequence of p22-phox (aa  149-162)  abolished the 
binding between GST-p47-SH3 and GST-p22  (aa 127-195), 
while peptides based on the COOH-terminal  Pro-rich se- 
quence (aa 170-195) or containing the P156Q mutation, were 
ineffective. These results suggest that the interaction between 
the SH3 regions of p47-phox and p22-phox depends on Pro 
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tion is critical for assembly of an active enzyme. 
Leto et al. (51) explored this possibility in transfected cell 
lin~ Transf~ztion ofwtp22-phox, but not p22-phax containing 
the P156Q mutation, into p22-phox-deficient B cell lines cor- 
rected the defect in NADPH oxidase activation.  Also, the 
ability of p47-phox to translocate to the membrane depended 
on the presence of wtp22-phox in K562 cells transfected to 
express both proteins. In contrast, p47-phox did not translo- 
cate in K562 cells co-transfected with the P156Q mutant form 
of p22-phox. An article by Leusen et al.  (57),  appearing in 
this issue of The  Journal of  Experirnental  Medicine,  extends these 
results in a study using neutrophils from a patient with the 
P156Q mutation in p22-phox. Cells from the patient expressed 
normal levels  of a cytochrome bsss that  was nonfunctional 
for  activation  of NADPH  oxidase,  in  agreement  with  a 
previous report (56). Translocation of p47-phox and p67-phox 
to the membrane did not occur in either stimulated intact 
cells from the patient or the cell-free reconstitution system. 
The  "nonfunctional"  cytochrome was capable of electron 
transfer in an artificial  cell-free system not requiring  cyto- 
solic components (37). Thus,  the P156Q mutation in p22- 
phox found in this patient prevents assembly of the NADPH 
oxidase complex, and no enzyme activation occurs. Collec- 
tively, these data support a model in which assembly of the 
cytosolic components  with  cytochrome bss8, mediated  by 
SH3-region/Pro-rich sequence interactions between p47-phox 
and p67-phox and between p47-phox and p22-phox, results 
in a conformational change in gp91-phox necessary for trans- 
port of electrons from NADPH to 02 (Fig.  2). 
The P156Q mutation in p22-phox is the second example 
of a genetic disease caused by disruption of protein-protein 
interactions  mediated by SH3 domains.  Zhu et al.  (58) re- 
cently reported a deletion in the SH3 region of Bruton's tyro- 
sine kinase, which resulted in X-linked agammaglobulinemia. 
The third SH3-dependent interaction of NADPH oxidase 
components involves intramolecular binding of the SH3 do- 
mains of p47-phox to Pro-rich  sequences within  the mole- 
cule. GST-fusion proteins containing the SH3 regions of p47- 
phox were shown by Leto et al.  (51)  and Sumimoto et al. 
(53) to bind to regions of p47-phox containing Pro-rich se- 
quences.  Data from  the two groups  are consistent in im- 
plicating the most COOH-terminal Pro-rich sequence in p47- 
phox (aa 358-390) as one binding site. Leto et al. also provided 
evidence  suggesting  the  most  NH2-terminal  Pro-rich  se- 
quence (aa 70-84) is a second target. Additional studies with 
synthetic peptides and mutant or truncated proteins are needed 
to pinpoint the interaction sites more clearly.  Leto et al. (51) 
speculate that such an intramolecular interaction in p47-phox 
folds the molecule in an "inactive" state, and the interaction 
must be disrupted in order for assembly of NADPH oxidase 
Cytochrome I)5. 
.pOl.phox  ! ~  ~  ~=-p~ox 
Membrane 
p47-phox  p67-phox 
Figure  2.  Model  for SH3-dependent assembly  of NADPH oxidase. In 
the resting state, p47-phox  is folded such that the SH3 regions undergo 
an intramolecular interaction with Pro-rich sequences near the NHz- 
and COOH-terminal portions of the protein. Activation induces a con- 
formational change in p47-phax, allowing  the SH3 domains to bind Pro-rich 
sequences in the cytoplasmic tail of p22-phox.  The P156Q mutation in 
p22-phax (circled)  disrupts this interaction. After activation, the COOH-ter- 
minal Pro-rich sequence of p47-phox  is also free to interact with the 
COOH-terminal SH3 region of p67-phox.  A comple~  between p47-phox 
and p67-/,hax may exist before  activation  and could  involve  other interactions 
(not illustrated). The consequence  of the SH3-mediated  assembly  process 
may be the induction of conformational changes in gp91-phox,  which are 
permissive for dectron transfer between  NADPH and 02 (not illustrated). 
(Reproduced  from Proa Natl. Acad.  Sci. USA, 1994, 91:10650, by copyright 
permission of the National Academy of Sciences [Washington, DC].) 
components to occur (Fig. 2). Experimental evidence to sup- 
port this model was provided by Sumimoto et al.  (53).  A 
monoclonal antibody specific for the SH3 domains of p47- 
phox immunoprecipitated  native p47-phox (present in cyto- 
solic fractions from HL-60 cells differentiated along the neu- 
trophilic pathway) only in the presence of arachidonic acid 
or SDS.  These amphiphilic  molecules are used in cell-free 
reconstitution systems to induce assembly and activation of 
NADPH oxidase. Possibly, the amphiphiles induce a confor- 
mational change in p47-phox, "unmasking" the SH3 regions 
to allow interaction with other NADPH oxidase components. 
One can speculate that a physiological mechanism to achieve 
this conformational  change is phosphorylation  of multiple 
sites  in the COOH-terminal  region  of p47-phox. 
Conclusion.  Considerable progress has been made in un- 
derstanding  the SH3-dependent interactions between com- 
ponents of NADPH oxidase. Such interactions appear to be 
crucial for assembly of an active enzyme. An intriguing model 
for SH3-mediated assembly, consistent with the data sum- 
marized here, has been put forth by Leto et al. (51) (see Fig. 
2 and discussions above). Future research with this complex 
enzyme system will test and modify this model. What a fas- 
cinating  story is unfolding! 
I thank  Tom Leto for sharing his results and model prior  to publication. 
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